SD

Director Director DIN 03195795
DIN 03195795 First appointment Aug 2010 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Aug 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Som Dutt

Data last updated:

Som Dutt was a Director at Rasiele Biotech Private Limited (2011–2017) and Director at Maureen Pharmaceuticals Private Limited (from 2010). The companies operate in Healthcare.

DIN 03195795
Primary Designation Director
Industry Healthcare
First Appointment 27 Aug 2010
Oldest Company Age 16 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rasiele Biotech Private Limited U24232DL2011PTC212907
Director20 Jan 20112011₹7.8 Lakh (FY 2017)Strike Off
Director27 Aug 20102010Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Maureen Pharmaceuticals Private Limited
Rasiele Biotech Private Limited
Premium access

Shareholding and investment profile for Som Dutt

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Som Dutt

Som Dutt was first appointed on 27 Aug 2010 as Director at Maureen Pharmaceuticals Private Limited. The most recent appointment on record is 20 Jan 2011 at Rasiele Biotech Private Limited.

Som Dutt held 2 earlier board appointments: Rasiele Biotech Private Limited (Director, 20 Jan 2011 to 12 May 2017); Maureen Pharmaceuticals Private Limited (Director, from 27 Aug 2010).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available